AHSC - Imperial College Academic Health Science Centre ☰ Menu
  • About Imperial College AHSC
    • The AHSC Partners
    • How we work
    • Our history
    • Our Impact
    • Imperial College Health Partners
  • Our Vision and Strategy
  • Research Disease Areas
    • Cancer
    • Infection and antimicrobial resistance
    • Cardiovascular
    • Lung disease
    • Metabolic Medicine
    • Neurological and neurodegenerative disease
  • Education and Learning
  • AHSC Seminars
  • News & Events
  • Contact us
Search
  • About this site
  • Cookies policy

© 2022 Imperial College Academic Health Science Centre

Imperial College Academic Health Science Centre

Home » News » Epigenetic study highlights drug targets for allergies and asthma

Epigenetic study highlights drug targets for allergies and asthma

  • Share
  • Share on Twitter
  • Share on Facebook
  • Share on LinkedIn

Related News

September 18, 2017 Imperial wins funds for medical technology Imperial College London has been awarded funding to establish a centre of excellence in medical technology. The National Institute for Health Research has awarded over £1.3 million to host the NIHR London In Vitro Diagnostics Co-operative (NIHR London IVD Co-operative). The centre in partnership with Imperial College Healthcare NHS Trust, Royal Brompton & Harefield NHS Foundation Trust and the Royal Marsden […]
June 30, 2022 Scientists discover mechanism controlling spread of pancreatic cancer
October 10, 2013 Imperial College Healthcare NHS Trust announces chief executive arrangements